TET2 and melanoma: In a murine melanoma model, TET2 deletion in myeloid cells resulted in reduced tumor burden and increased tumor-infiltrating T cells suggesting that TET2 promotes a myeloid immunosuppressive program in the tumor microenvironment (56).